Takhzyro (lanadelumab-flyo) is a prescription drug used to prevent hereditary angioedema attacks in adults and specific children. Like any medication, Takhzyro can lead to various side effects, including injection site reactions. These side effects may vary in severity and duration, so it is crucial to monitor and report any concerning symptoms to your healthcare provider.
While using Takhzyro, some individuals may experience mild side effects that are generally temporary and manageable. These side effects can range from skin reactions to mild pain and discomfort. It is important to note that not all mild side effects may be listed here, so consulting the prescribing information for Takhzyro is advisable.
Based on clinical trials, Takhzyro is not typically associated with severe side effects apart from allergic reactions. The occurrence of serious side effects such as an allergic reaction should be promptly addressed by contacting a healthcare provider. Allergic reactions can manifest as mild symptoms like rash or escalate to severe symptoms like difficulty breathing, requiring immediate medical attention.
One of the most common side effects reported with Takhzyro is injection site reactions. These reactions can include pain, redness, bruising, swelling, itching, and skin rash. Proper administration techniques can help reduce the risk of injection site reactions. It is essential to avoid injecting Takhzyro into damaged or irritated skin and to rotate injection sites for each dose to minimize discomfort and irritation.
While increases in liver enzyme levels have been rarely reported with Takhzyro, it is crucial to monitor liver function periodically, especially for individuals with pre-existing liver conditions. Although Takhzyro is not known to cause liver damage, individuals with liver issues should inform their healthcare provider before starting treatment to ensure proper monitoring and management.
Before starting Takhzyro, it is essential to discuss your medical history with your healthcare provider, especially if you have liver conditions, previous allergic reactions to similar drugs, are pregnant or breastfeeding, or have a history of alcohol consumption. These factors can influence the suitability of Takhzyro for your specific circumstances, so open communication with your healthcare provider is key.
By understanding the potential side effects and risks associated with Takhzyro, individuals can make informed decisions about their treatment plan and actively participate in their healthcare journey. It is important to prioritize open communication with healthcare providers, report any concerning symptoms promptly, and follow recommended guidelines for safe and effective use of Takhzyro.